M&T Bank
KNSA icon

M&T Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History

M&T Bank’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,735
Closed -$608K – 1615
2024
Q4 		$608K Hold
30,735
– – ﹤0.01% 1093
2024
Q3 		$768K Sell
30,735
-5,654
-16% -$138K ﹤0.01% 996
2024
Q2 		$680K Buy
36,389
+55
+0.2% +$1.03K ﹤0.01% 999
2024
Q1 		$717K Sell
36,334
-78
-0.2% -$1.52K ﹤0.01% 998
2023
Q4 		$638K Sell
36,412
-601
-2% -$9.88K ﹤0.01% 1035
2023
Q3 		$643K Sell
37,013
-20,255
-35% -$341K ﹤0.01% 981
2023
Q2 		$806K Buy
57,268
+13,306
+30% +$178K ﹤0.01% 944
2023
Q1 		$474K Buy
43,962
+14,298
+48% +$188K ﹤0.01% 1135
2022
Q4 		$444K Sell
29,664
-8,776
-23% -$128K ﹤0.01% 1150
2022
Q3 		$494K Sell
38,440
-8,856
-19% -$101K ﹤0.01% 1085
2022
Q2 		$458K Hold
47,296
– – ﹤0.01% 1045
2022
Q1 		$470K Buy
47,296
+25,612
+118% +$271K ﹤0.01% 1021
2021
Q4 		$255K Buy
21,684
+1,183
+6% +$14.5K ﹤0.01% 1330
2021
Q3 		$234K Buy
20,501
+9,611
+88% +$125K ﹤0.01% 1364
2021
Q2 		$152K Hold
10,890
– – ﹤0.01% 1488
2021
Q1 		$202K Buy
+10,890
New +$223K ﹤0.01% 1422
2020
Q1 		– Sell
-16,299
Closed -$180K – 1630
2019
Q4 		$180K Buy
16,299
+2,808
+21% +$24.4K ﹤0.01% 1278
2019
Q3 		$115K Buy
13,491
+3,092
+30% +$34.2K ﹤0.01% 1490
2019
Q2 		$141K Buy
+10,399
New +$161K ﹤0.01% 1466

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

M&T Bank's KNSA Position: Q1 2025 in Review

M&T Bank sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2025, closing a stake of 30,735 shares — an estimated $608K sold.

M&T Bank first reported a position in KNSA in Q2 2019 and held it in 19 quarters. The position peaked at $806K in Q2 2023. 176 funds tracked by Wall St. Rank hold KNSA as of Q1 2025.

  • M&T Bank reported no remaining Kiniksa Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 30,735 Kiniksa Pharmaceuticals shares in Q1 2025, an estimated $608K.
  • M&T Bank first reported a position in Kiniksa Pharmaceuticals in Q2 2019 and held it in 19 quarters.
  • M&T Bank's Kiniksa Pharmaceuticals position peaked at $806K in Q2 2023.
  • 176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.